P.A. Merle

A novel cryptic CBFB-MYH11 gene fusion present at birth leading to acute myeloid leukemia and allowing molecular monitoring for minimal residual disease

Poddighe, P. J., Veening, M. A., Mansur, M. B., Loonen, A. H., Westers, T. M., Merle, P. A., Wessels, J. W., de Haas, V., Kors, W. A., Bhola, S. L., Wondergem, M. J., Ford, A. M. & Kaspers, G. J. L., 1 Mar 2018, In: Human Pathology: Case Reports. 11, p. 34-38 5 p.

Research output: Contribution to journal › Article › Academic › peer-review

Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid

Verhagen, H. J. M. P., Smit, M. A., Rutten, A., Denkers, F., Poddighe, P. J., Merle, P. A., Ossenkoppele, G. J. & Smit, L., 28 Jan 2016, In: Blood. 127, 4, p. 458-463

Research output: Contribution to journal › Article › Academic › peer-review

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR

White, H., Deprez, L., Corbisier, P., Hall, V., Lin, F., Mazoua, S., Trapmann, S., Aggerholm, A., Andrikovics, H., Akiki, S., Barbany, G., Boeckx, N., Bench, A., Catherwood, M., Cayuela, J. M., Chudleigh, S., Clench, T., Colomer, D., Daraio, F., Dulucq, S., & 51 othersFarrugia, J., Fletcher, L., Foroni, L., Ganderton, R., Gerrard, G., Gineikiene, E., Hayette, S., El Housni, H., Izzo, B., Jansson, M., Johnels, P., Jurcek, T., Kairisto, V., Kizilors, A., Kim, D. W., Lange, T., Lion, T., Polakova, K. M., Martinelli, G., McCarron, S., Merle, P. A., Milner, B., Mitterbauer-Hohendanner, G., Nagar, M., Nickless, G., Nomdedeu, J., Nymoen, D. A., Leibundgut, E. O., Ozbek, U., Pajic, T., Pfeifer, H., Preudhomme, C., Raudsepp, K., Romeo, G., Sacha, T., Talmaci, R., Touloumenidou, T., van der Velden, V. H. J., Waits, P., Wang, L., Wilkinson, E., Wilson, G., Wren, D., Zadro, R., Ziermann, J., Zoi, K., Mueller, M. C., Hochhaus, A., Schimmel, H., Cross, N. C. P. & Emons, H., 2015, In: Leukemia. 29, 2, p. 369-376

Research output: Contribution to journal › Article › Academic › peer-review

A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment

Janssen, J. J. W. M., Berendse, H. W., Schuurhuis, G. J., Merle, P. A. & Ossenkoppele, G. J., 2009, In: American Journal of Hematology. 84, 10, p. 679-682

Research output: Contribution to journal › Article › Academic › peer-review

Immunophenotypical minimal residual disease as a short term endpoint for monitoring effects of targeted inhibitors in acute myeloid leukemia.

Hess, CJ., Feller, N., Denkers, F., Merle, PA., Ossenkoppele, GJ., Waisfisz, Q. & Schuurhuis, GJ., 16 Nov 2005, In: Blood. 106, 11, p. 162A-162A

Research output: Contribution to journal › Meeting Abstract › Academic